Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
QuintilesIMS
US Army
Chubb
Healthtrust
Merck
Cantor Fitzgerald
Cerilliant
Baxter

Generated: June 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 207938

« Back to Dashboard

NDA 207938 describes PIROXICAM, which is a drug marketed by Cycle Pharms Ltd, Egis, Flamingo Pharms, Hikma Pharms, Ivax Sub Teva Pharms, Laboratorios Cinfa, Micro Labs, Mylan, Mylan Ireland Ltd, PII, SCS, Strides Pharma, Sun Pharm Industries, Teva, Teva Pharms, Unichem Labs Ltd, and Watson Labs, and is included in twenty-two NDAs. It is available from twenty-four suppliers. Additional details are available on the PIROXICAM profile page.

The generic ingredient in PIROXICAM is piroxicam. There are sixteen drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the piroxicam profile page.
Summary for 207938
Tradename:PIROXICAM
Applicant:Flamingo Pharms
Ingredient:piroxicam
Patents:0
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 207938
Medical Subject Heading (MeSH) Categories for 207938
Suppliers and Packaging for NDA: 207938
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PIROXICAM piroxicam CAPSULE;ORAL 207938 ANDA Northstar Rx LLC 16714-411 E 16714-411-01
PIROXICAM piroxicam CAPSULE;ORAL 207938 ANDA Northstar Rx LLC 16714-412 E 16714-412-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength10MG
Approval Date:Sep 9, 2016TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength20MG
Approval Date:Sep 9, 2016TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Moodys
McKinsey
Accenture
US Department of Justice
Dow
AstraZeneca
Colorcon
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.